Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins
Influenza is an acute respiratory infectious disease caused by the influenza virus, affecting people globally and causing significant social and economic losses. Due to the inevitable limitations of vaccines and approved drugs, there is an urgent need to discover new anti-influenza drugs with differ...
Saved in:
Main Authors: | Lingxin Hou (Author), Ying Zhang (Author), Han Ju (Author), Srinivasulu Cherukupalli (Author), Ruifang Jia (Author), Jian Zhang (Author), Bing Huang (Author), Arianna Loregian (Author), Xinyong Liu (Author), Peng Zhan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
by: Jiwei Zhang, et al.
Published: (2023) -
Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors
by: Shenghua Gao, et al.
Published: (2022) -
Emerging drug design strategies in anti-influenza drug discovery
by: Chuanfeng Liu, et al.
Published: (2023) -
An analysis of the role of HnRNP C dysregulation in cancers
by: Liyi Mo, et al.
Published: (2022) -
Cornerstones in Contemporary Inorganic Chemistry
Published: (2022)